TECHWIRE 30
(CIX: WRAL30)  996.45  down arrow-8.5  (-0.85 %)  Updated: 08:10 PM EDT, Apr 23 2014
(NQ: Apple)  524.75  down arrow-6.95  (-1.31 %)  Updated: 08:10 PM EDT, Apr 23 2014
(NY: QUINTILES)  49.47  down arrow-0.48  (-0.96 %)  Updated: 06:40 PM EDT, Apr 23 2014
(OP: BASF SE)  112.59  down arrow-0.25  (-0.22 %)  Updated: 08:10 PM EDT, Apr 23 2014
(NQ: BioCryst)  8.55  down arrow-0.65  (-7.07 %)  Updated: 08:10 PM EDT, Apr 23 2014
(NQ: BioDelivery)  8.66  up arrow+0.19  (2.24 %)  Updated: 08:10 PM EDT, Apr 23 2014
(NQ: CEMP)  9.92  down arrow-0.49  (-4.71 %)  Updated: 08:10 PM EDT, Apr 23 2014
(NQ: Cisco Systems)  23.50  down arrow-0.02  (-0.09 %)  Updated: 08:10 PM EDT, Apr 23 2014
(NQ: Cornerstone)  9.49    (0 %)  Updated: 08:10 PM EST, Feb 03 2014
(NQ: Cree)  51.04  down arrow-7.01  (-12.08 %)  Updated: 08:10 PM EDT, Apr 23 2014
(NQ: DARA)  1.88  up arrow+0.05  (2.73 %)  Updated: 08:10 PM EDT, Apr 23 2014
(NY: EMC CORPORATION)  25.91  down arrow-0.85  (-3.18 %)  Updated: 06:40 PM EDT, Apr 23 2014
(NQ: Extreme Networks)  5.70  down arrow-0.09  (-1.55 %)  Updated: 08:10 PM EDT, Apr 23 2014
(NQ: Facebook)  61.36  down arrow-1.67  (-2.65 %)  Updated: 08:10 PM EDT, Apr 23 2014
(NY: GLAXOSMITHKLINE)  55.14  down arrow-0.16  (-0.29 %)  Updated: 06:40 PM EDT, Apr 23 2014
(NQ: GOOG)  526.94  down arrow-7.87  (-1.47 %)  Updated: 08:10 PM EDT, Apr 23 2014
(NY: IBM)  191.73  down arrow-0.42  (-0.22 %)  Updated: 06:40 PM EDT, Apr 23 2014
(NY: LH)  99.85  down arrow-0.53  (-0.53 %)  Updated: 06:40 PM EDT, Apr 23 2014
(OP: Lenovo Group)  22.76  down arrow-0.43  (-1.85 %)  Updated: 08:10 PM EDT, Apr 23 2014
(NY: MRK)  57.50  down arrow-0.27  (-0.47 %)  Updated: 06:40 PM EDT, Apr 23 2014
(NQ: Microsoft Corp)  39.69  down arrow-0.3  (-0.75 %)  Updated: 08:10 PM EDT, Apr 23 2014
(NQ: NetApp)  35.87  down arrow-0.18  (-0.49 %)  Updated: 08:10 PM EDT, Apr 23 2014
(NY: NOVARTIS AG)  86.17  down arrow-0.39  (-0.45 %)  Updated: 06:40 PM EDT, Apr 23 2014
(OP: Novozymes A/S)  46.99  up arrow+0.98  (2.13 %)  Updated: 08:10 PM EDT, Apr 23 2014
(NY: PFIZER)  30.92  down arrow-0.08  (-0.26 %)  Updated: 06:40 PM EDT, Apr 23 2014
(NQ: Pozen)  9.22  down arrow-0.03  (-0.32 %)  Updated: 08:10 PM EDT, Apr 23 2014
(NY: RED HAT)  50.05  down arrow-0.85  (-1.67 %)  Updated: 06:40 PM EDT, Apr 23 2014
(NQ: BBRY)  7.36  up arrow+0.07  (0.96 %)  Updated: 08:10 PM EDT, Apr 23 2014
(NQ: Salix)  109.95  up arrow+0.88  (0.81 %)  Updated: 08:10 PM EDT, Apr 23 2014
(NQ: SQI)  26.18  down arrow-0.8  (-2.97 %)  Updated: 08:10 PM EDT, Apr 23 2014

Posts tagged “Duke”

Updated August 23, 2013

Premium Lock Regado Biosciences shows some 'pop' on IPO day

Shares in Regado Biosciences show some significant appeal to investors on IPO day, jumping more than 30 percent at one point before fading. The company is commercializing technology developed at Duke University.

Regado's pipeline Regado's pipeline

August 22, 2013

Premium Lock Duke spinout Regado Biosciences goes public - but for less cash that hoped

Regado The life science company, which has licensed technology from Duke University, had hoped to raise as much as $80.

July 29, 2013

Premium Lock Duke Institute for Health Innovation launches to connect clinicians, companies

A new Duke University institute intended to foster innovation from Duke Health is having its coming out party. Read how the institute plans to bring new ideas to health care.

Tom Kaminski, Duke Institute for Health Innovation Tom Kaminski, Duke Institute for Health Innovation

July 22, 2013

Premium Lock Duke study: Fish oil derivative could ease neuropathic pain

A compound derived from fish oil showed the ability to reduce pain in a Duke University study, suggesting it could be developed into an alternative to addictive opioid pain meds.

Duke University research on pain treatments Duke University research on pain treatments

July 19, 2013

Premium Lock Biomaterials from Duke hold promise for back pain treatment

Duke researchers have developed a biomaterial that could improve upon current techniques for treating degenerative disc disease. Read more about the research.

Duke biomaterial used for cell delivery Duke biomaterial used for cell delivery

June 24, 2013

Premium Lock Monsanto acquires Durham-based agbio startup

Monsanto GrassRoots Biotechnology, which has worked as a partner with Monsanto for several years, is now part of the agricultural giant.

June 13, 2013

Premium Lock Video games could train brain to make faster decisions, Duke study says

A Duke University study found that hours of gaming could be responsible for training the brain to make faster decisions from processing visual information.

Video gaming Video gaming

June 10, 2013

Premium Lock Bioengineered blood vessels from RTP firm start clinical trials at Duke

A blood vessel grown in a lab was implanted in the first U.S. patient this week. Read more about Humacyte, the RTP firm that developed this regenerative medicine technology.

Bioengineered blood vessel Bioengineered blood vessel

June 5, 2013

Premium Lock U.S. CFOs lag global firms in sustainability priorities, Duke survey says

Asia tops all regions in the emphasis CFOs place on corporate social responsibility. Read more findings from Duke University's quarterly survey of global financial executives.

Click here to open the YouTube video in a new window.

May 31, 2013

Premium Lock Regado Biosciences prices its IPO, aims for as much as $80M

Regado The life science company, which has licensed technology from Duke University, sets the pricing for its stock offering and how many shares its underwriters can purchase.

Updated May 30, 2013

Premium Lock More than ever, 'City of Medicine' fits Durham's new economy

New Bull City, Day Eight: In 1988, Durham had just four total life science companies. Now the city has 92 firms and counting. Read how the life sciences took root in the "City of Medicine" as WRALTechWire's report about the rebirth of Durham continues.

From tobacco to biotech ... From tobacco to biotech ...

Updated May 29, 2013

Premium Lock Biotech in Durham builds on Venable building's history

Venable Center The New Bull City: A former tobacco building now houses several life science related firms, and space once used to process tobacco now offers research space. The history of the Venable center reflects Durham,s transition from a tobacco town to a tech hub.

Updated May 24, 2013

Premium Lock Durham's infrastructure for success: Revitalized buildings, high-octane people, organizations

New Bull City, Day Five: The rebirth of Durham over the past two decades came through a powerful convergence of people, places, a university, and organizations. Buildings were rebuilt to accommodate new businesses, not tobacco. New structures were added. But the key ingredient is the people: The leaders and organizations who have provided the life blood to turn new and improved buildings into the sites for a new community.

The American Underground - where new businesses are born The American Underground - where new businesses are born

May 22, 2013

Premium Lock Quintiles, DCRI shine in CRO industry survey

Quintiles and the Duke Clinical Research Institute are very different providers of clinical trial services but pharma executives give both high marks. Learn what makes them stand out.

ISR 2013 CRO Benchmarking Report ISR 2013 CRO Benchmarking Report

Updated May 13, 2013

Premium Lock Titans of tech seek to excite UNC, Duke grads about a future beyond themselves

In graduation speeches at Duke and UNC-Chapel Hill respectively, Melinda Gates and Steve Case point to technology as a tool to build a better world. Will the graduates listen?

Time's cover Time's cover

May 8, 2013

Premium Lock Billionaire founder's latest 'gift' to NC Research Campus could be inflection point

David Murdock, the founder of the N.C. Research Campus in Kannapolis, is announcing another donation today to what Oprah Winfrey has described as his "gift to humanity." Will the endowment he is making secure the NCRC's future as a true hub for health research?

David Murdock at a recent NCRC event. David Murdock at a recent NCRC event.

Updated May 6, 2013

Premium Lock Billionaire Murdock to make another gift to NC Research Campus

David Murdock, the billionaire owner of Dole Food and founder of the N.C. Research Campus in Kannapolis, will announce another gift to the campus on Wednesday. Murdock has already invested more than $700 million of his own fortune in the project.

NCRC's massive main building. NCRC's massive main building.

Updated April 30, 2013

Premium Lock Another RTP biotech company files to go public

Going public An emerging biotech company focused on drugs to control bleeding is the latest firm with major operations and links to the Triangle to seek to go public. WRALTechWire Insiders can find out more.

Techwire Inside Partners
The Skinny: A Blog by Rick Smith

OUR INSIDERS

Dr. Mike Walden
Tech economy
Vivek Wadhwa
Commentary
Frank Vinluan
Life science
Scroll